Jan 5, 2022
This one goes out to all you atopic humans. 🤝 🎨 AllergicClub
seen from Chile
seen from T1
seen from Indonesia
seen from Netherlands
seen from Pakistan
seen from Indonesia
seen from India
seen from United Kingdom
seen from Malaysia
seen from Türkiye
seen from United States
seen from Italy
seen from United Kingdom
seen from Tunisia
seen from Russia
seen from United States
seen from Indonesia
seen from Türkiye
seen from Saudi Arabia
seen from Singapore
This one goes out to all you atopic humans. 🤝 🎨 AllergicClub
The Brazil Atopic Dermatitis Therapeutics Market was valued at US $308 Mn in 2022, and is predicted to grow at (CAGR) of 9.8% from 2023 to 2030, to US $650 Mn by 2030. The key drivers of this industry include the upward trend in prevalence of Atopic Dermatitis (AD), supportive government policies and shifting treatment preferences. The industry is primarily dominated by players such as Sanofi, AbbVie, Pfizer, Bayer, GlaxoSmithKline, Merck among others.
Atopic Scalp Dermatitis, Guide to Atopic Scalp Dermatitis,